Welcome to our dedicated page for InfuSystem Holdings news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on InfuSystem Holdings stock.
InfuSystem Holdings, Inc. (NYSE American: INFU) is a growing healthcare service provider specializing in delivering infusion pumps and related products and services to patients across the United States and Canada. The company is headquartered in Rochester Hills, Michigan, and operates from five strategically located facilities to ensure comprehensive coverage. InfuSystem facilitates outpatient care through a two-platform model: Patient Services and Device Solutions.
Patient Services offers a last-mile solution for clinic-to-home healthcare. This segment includes Oncology, Pain Management, Wound Therapy, and Lymphedema services. It focuses on delivering complex durable medical equipment directly to patients, ensuring they receive continuous care at home or other non-hospital settings.
Device Solutions supports the Patient Services platform by providing direct payer rentals, pump and consumable sales, and biomedical services and repair. This segment's goal is to enhance service orientation and secure additional business from its direct payer clients.
InfuSystem's innovative approach and strategic partnerships have made it a leader in the healthcare service sector. Recently, the company announced a sales and marketing partnership with Dignitana AB, a leader in scalp cooling technology. This collaboration allows InfuSystem to offer the FDA-cleared DigniCap Scalp Cooling System to help minimize hair loss for cancer patients undergoing chemotherapy. This partnership highlights InfuSystem's commitment to enhancing patient care and expanding its product offerings.
InfuSystem boasts a robust financial position, underpinned by its diversified service offerings and strong market presence. The company continues to explore new opportunities to grow and enhance its service delivery, ensuring that it remains at the forefront of the healthcare industry.
InfuSystem Holdings, Inc. (NYSE American: INFU), a leading national health care service provider, has announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, before the market opens. The company will host a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results.
InfuSystem operates under a two-platform model: Patient Services, which includes Oncology, Pain Management, and Wound Therapy businesses, and Device Solutions, which supports Patient Services and focuses on direct payer clients. The company provides outpatient care solutions for durable medical equipment manufacturers and health care providers, with a focus on clinic-to-home healthcare for complex treatments.
InfuSystem will present at the Sidoti Small Cap Virtual Investor Conference on June 12, 2024, at 8:30 a.m. Eastern Time. The conference will feature presentations from CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance. Investors can access the live webcast and replay on InfuSystem's website. Additionally, the management will host virtual one-on-one meetings throughout the day. InfuSystem, based in Rochester Hills, Michigan, provides outpatient care for durable medical equipment through two main platforms: Patient Services and Device Solutions. The company operates several Centers of Excellence in the USA and Canada.
InfuSystem, a national healthcare service provider, announced a $20 million stock repurchase program authorized by its Board of Directors. This program extends through June 30, 2026, and replaces the previous authorization expiring June 30, 2024, under which 550 thousand shares were repurchased for $6.2 million. The new program highlights confidence in the company’s operations, financial strength, and future outlook, allowing flexible share repurchases under favorable conditions. CEO Richard DiIorio emphasized the company’s commitment to strategic investments for sustainable growth while considering opportunistic buybacks.
InfuSystem reported record net revenues of $32.0 million in the first quarter of 2024, representing a 5% growth from the prior year. The gross profit increased by 10%, with a gross margin of 51.5%. Adjusted EBITDA decreased by 9% compared to the prior year. The company's liquidity totaled $45.4 million as of March 31, 2024.
InfuSystem Holdings, Inc. (NYSE American: INFU) will report first quarter 2024 financial results on May 9, 2024. The company will conduct a conference call at 9:00 a.m. Eastern Time to discuss the results. InfuSystem is a leading national health care service provider, offering outpatient care for durable medical equipment manufacturers and health care providers.
FAQ
What is the current stock price of InfuSystem Holdings (INFU)?
What is the market cap of InfuSystem Holdings (INFU)?
What services does InfuSystem Holdings, Inc. provide?
What are the two platforms of InfuSystem's services?
Where is InfuSystem Holdings, Inc. headquartered?
Who are InfuSystem's recent partners?
What is the DigniCap Scalp Cooling System?
What areas does InfuSystem serve?
What is the objective of the Patient Services platform?
How does the Device Solutions platform support InfuSystem?
What are InfuSystem's business segments?
How does InfuSystem contribute to patient care?
